These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 6817447)

  • 21. [Effect of a single administration of cryoprotein and plasma on factor VIII in hemophilia A].
    Vlcková M; Vorlová Z
    Vnitr Lek; 1980 Nov; 26(11):1101-6. PubMed ID: 6789551
    [No Abstract]   [Full Text] [Related]  

  • 22. [Studies on the usefulness of double filtration plasmapheresis in a hemophilia A patient with anti-factor VIII antibody (inhibitor)].
    Okubo S; Ikuma T; Hamaguchi Y; Yasunaga K
    Rinsho Ketsueki; 1985 May; 26(5):701-8. PubMed ID: 3932716
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical experience with polyelectrolyte-fractionated porcine factor VIII concentrate in the treatment of hemophiliacs with antibodies to factor VIII.
    Kernoff PB; Thomas ND; Lilley PA; Matthews KB; Goldman E; Tuddenham EG
    Blood; 1984 Jan; 63(1):31-41. PubMed ID: 6418234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Factor VIII inhibitor-caused hemophilia].
    Peto I; Bánhegyi D; Nemesánszky E; Köves A; Sas G
    Orv Hetil; 1977 Sep; 118(36):2145-9. PubMed ID: 917507
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of hemorrhage in a patient with severe hemophilia A and factor VIII antibodies].
    Gassmann AE; Kerkhofs H; Leeksma CH
    Schweiz Med Wochenschr; 1970 Oct; 100(41):1734-6. PubMed ID: 5480542
    [No Abstract]   [Full Text] [Related]  

  • 26. What can we learn from the immune response to human factor VIII in a mouse model of hemophilia A?
    Reipert BM; Schwarz HP
    Thromb Haemost; 2002 Aug; 88(2):374-5. PubMed ID: 12195723
    [No Abstract]   [Full Text] [Related]  

  • 27. Induction of tolerance using porcine factor VIII.
    Hay CR; Laurian Y
    Vox Sang; 1996; 70 Suppl 1():68-9. PubMed ID: 8869473
    [No Abstract]   [Full Text] [Related]  

  • 28. HLA antigens and factor VIII antibody in classic hemophilia. European study group of factor VIII antibody.
    Frommel D; Allain JP; Saint-Paul E; Bosser C; Noël B; Mannucci PM; Pannicucci F; Blombäck M; Prou-Wartelle O; Muller JY
    Thromb Haemost; 1981 Dec; 46(4):687-9. PubMed ID: 6800049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of anamnestic response after transfusion of washed red blood cells in haemophilia A patients with antibody to factor VIII.
    Laurian Y; Girma JP; Allain JP; Verroust F; Larrieu MJ
    Scand J Haematol; 1982 Mar; 28(3):233-7. PubMed ID: 6806896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitor development in a multitransfused patient with severe haemophilia A.
    van den Berg HM; Roosendaal G; Voorberg J; Mauser-Bunschoten EP
    Thromb Haemost; 1999 Jul; 82(1):151-2. PubMed ID: 10456472
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibodies to factor VIII. 3. Characterization of the immune response to iso- and heteroantigens in hemophilia A.
    Allain JP; Vedrenne J; Frommel D
    Pathol Biol (Paris); 1973 Nov; 21():Suppl:76-9. PubMed ID: 4128454
    [No Abstract]   [Full Text] [Related]  

  • 32. Porcine factor VIII in factor VIII antibody-positive hemophiliacs.
    Kessler CM
    J Interferon Res; 1994 Aug; 14(4):175-6. PubMed ID: 7822866
    [No Abstract]   [Full Text] [Related]  

  • 33. Factor VIII inhibitors.
    Gilles JG; Jacquemin MG; Saint-Remy JM
    Thromb Haemost; 1997 Jul; 78(1):641-6. PubMed ID: 9198231
    [No Abstract]   [Full Text] [Related]  

  • 34. Antigenic differences among bovine and porcine Factor VIII concentrates.
    Edson JR; Swinehart CD
    Am J Clin Pathol; 1976 Jun; 65(6):957-63. PubMed ID: 59540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hemophilia A with inhibitor].
    Takahashi I
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):498-501. PubMed ID: 9833554
    [No Abstract]   [Full Text] [Related]  

  • 36. [Safe and cost-conscious supply of factor-VIII-deficient Swiss hemophiliacs with AHF preparations].
    Stampfli K
    Ther Umsch; 1977 Oct; 34(10):717-24. PubMed ID: 918896
    [No Abstract]   [Full Text] [Related]  

  • 37. Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors.
    Reipert BM; van Helden PM; Schwarz HP; Hausl C
    Br J Haematol; 2007 Jan; 136(1):12-25. PubMed ID: 17222196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Circulating anticoagulants during hemophilia].
    Josso F; Cosson A; Gazengel C; Allain JP
    Rev Fr Transfus; 1972 Dec; 15(4):281-98. PubMed ID: 4659598
    [No Abstract]   [Full Text] [Related]  

  • 39. Discrepancies in measured factor VIII activity in patients treated with factor VIII concentrate of human or porcine origin.
    Teitel JM; Lau HK; Garvey MB
    Thromb Haemost; 2002 Jul; 88(1):159-60. PubMed ID: 12152659
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical course of factor VIII inhibitors developed after exposure to a pasteurised Dutch concentrate compared to classic inhibitors in hemophilia A.
    Mauser-Bunschoten EP; Rosendaal FR; Nieuwenhuis HK; Roosendaal G; Briët E; van den Berg HM
    Thromb Haemost; 1994 Jun; 71(6):703-6. PubMed ID: 7974335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.